INCLUSION COMPOUNDSFRANK SG.1975; J. PHARM. SCI.; U.S.A.; DA. 1975; VOL. 64; NO 10; PP. 1585-1604; BIBL. 3 P.Article

PHASE SOLUBILITY ANALYSIS AND PMR STUDY OF COMPLEXING BEHAVIOR OF DINOPROSTONE WITH BETA -CYCLODEXTRIN IN WATERFRANK SG; CHO MJ.1978; J. PHARM. SCI.; USA; DA. 1978; VOL. 67; NO 12; PP. 1665-1668; BIBL. 24 REF.Article

PHASE TRANSITIONS IN BINARY MIXTURES OF CHOLESTERYL ESTERSFRANK SG; BYRD BG.1972; J. PHARM. SCI.; U.S.A.; DA. 1972; VOL. 61; NO 11; PP. 1762-1765; BIBL. 21 REF.Serial Issue

IN VITRO RELEASE OF LIDOCAINE FROM PLURONIC F-127 GELSPAIE CHIE CHEN CHOW; FRANK SG.1981; INT. J. PHARM.; ISSN 0378-5173; NLD; DA. 1981; VOL. 8; NO 2; PP. 89-99; BIBL. 16 REF.Article

PROLONGED DRUG RELEASE FROM MULTIPLE EMULSIONS.BRODIN AF; KAVALIUNAS DR; FRANK SG et al.1978; ACTA PHARM. SUECICA; SUEDE; DA. 1978; VOL. 15; NO 1; PP. 1-12; BIBL. 9 REF.Article

A PSYCHOANALYTIC REINTERPRETATION OF THE EFFECTIVENESS OF SYSTEMATIC DESENSITIZATION: EXPERIMENTAL DATA BEARING ON THE ROLE OF MERGING FANTASIES = UNE REINTERPRETATION PSYCHANALYTIQUE DE L'EFFICACITE DE LA DESENSIBILISATION SYSTEMATIQUE: DONNEES EXPERIMENTALES PORTANT SUR LE ROLE DES FANTASMES DE SYMBIOSESILVERMAN LH; FRANK SG; DACHINGER P et al.1974; J. ABNORM PSYCHOL.; U.S.A.; DA. 1974; VOL. 83; NO 3; PP. 313-318; BIBL. 14REF.Article

PROTON MAGNETIC RESONANCE STUDY OF AEROSOL OT-WATER-ELECTROLYTE-N-OCTANE SYSTEMSFRANK SG; YUEH HO SHAW; LI NC et al.1973; J. PHYS. CHEM.; U.S.A.; DA. 1973; VOL. 77; NO 2; PP. 238-241; BIBL. 9 REF.Serial Issue

COMPARISON OF LIDOCAINE RELEASE FROM PLURONIC F-127 GELS AND OTHER FORMULATIONSPAI CHIE CHEN CHOW; FRANK SG.1981; ACTA PHARM. SUEC.; ISSN 0001-6675; SWE; DA. 1981; VOL. 18; NO 4; PP. 239-244; BIBL. 6 REF.Article

IN VITRO AND IN VIVO STUDIES ON LIDOCAINE FORMULATED IN AN O/W CREAM AND IN A POLYETHYLENE GLYCOL OINTMENTBROBERG F; BRODIN A; AKERMAN B et al.1982; ACTA PHARM. SUEC.; ISSN 0001-6675; SWE; DA. 1982; VOL. 19; NO 3; PP. 229-240; BIBL. 15 REF.Article

METABOLIC REDUCTION OF NALTREXONE. I. SYNTHESIS, SEPARATION AND CHARACTERIZATION OF NALOXONE AND NALTREXONE REDUCTION PRODUCTS AND QUALITATIVE ASSAY OF URINE AND BILE FOLLOWING ADMINISTRATION OF NALTREXONE, ALPHA -NALTREXOL, OR BETA -NALTREXOL. = REDUCTION METABOLIQUE DE LA NALTREXONE. I. SYNTHESE, SEPARATION ET CARACTERISATION DES PRODUITS DE REDUCTION DE LA NALOXONE ET DE LA NALTREXONE ET ANALYSE QUALITATIVE DE L'URINE ET DE LA BILE APRES ADMINISTRATION DE NALTREXONE, ALPHA -NALTREXOL OU BETA -NALTREXOLMALSPEIS L; BATHALA MS; LUDDEN TM et al.1975; RES. COMMUNIC. CHEM. PATHOL. PHARMACOL.; U.S.A.; DA. 1975; VOL. 12; NO 1; PP. 43-65; BIBL. 2 P.Article

TRITIATED NALTREXONE BINDING IN PLASMA FROM SEVERAL SPECIES AND TISSUE DISTRIBUTION IN MICE = LA FIXATION DE NALTREXONE TRITIEE DANS LE PLASMA DE PLUSIEURS ESPECES ET LA REPARTITION TISSULAIRE CHEZ LES SOURISLUDDEN TM; MALSPEIS L; BAGGOT JD et al.1976; J. PHARM. SCI.; U.S.A.; DA. 1976; VOL. 65; NO 5; PP. 712-716; BIBL. 25 REF.Article